Asymmetric cationic liposomes designed for heat-activated association with cells

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Advanced drug carriers are crucial for combination cancer therapies like hyperthermia-assisted chemotherapy.
• Liposomes offer potential for targeted drug delivery and release triggered by external stimuli such as heat.

Purpose of the Study:

• To design and evaluate liposomes with a heat-activated surface function for targeted drug delivery.
• To investigate the potential of asymmetric liposomes for localized drug release and enhanced cellular uptake in response to hyperthermia.

Main Methods:

• Fabrication of asymmetric liposomes using selective PEGylation of cationic lipids in the outer leaflet.
• Characterization of liposome properties including zeta potential and binding to model membranes at different temperatures.
• Assessment of dye release from liposomes and cellular uptake by hypopharyngeal carcinoma cells (FaDu) under hyperthermia conditions.

Main Results:

• Asymmetric liposomes exhibited neutral zeta potential and no binding to anionic membranes at physiological temperature.
• Heat activation (around 41°C) induced liposome binding to model membranes.
• Encapsulated hydrophilic dye release was observed at 40°C.
• Hyperthermia significantly enhanced the uptake of asymmetric liposomes by FaDu cells compared to normothermic conditions.

Conclusions:

• Asymmetric liposomes demonstrate tunable, heat-activated surface functionality.
• These liposomes show potential for localized drug delivery into cancer cells triggered by external hyperthermia.
• The developed system offers a promising platform for advanced targeted cancer therapy.